These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 35487034)

  • 21. Changes in Gait Characteristics During and Immediately After the 6-Minute Walk Test in Persons With Multiple Sclerosis: A Systematic Review.
    Abasıyanık Z; Kahraman T; Veldkamp R; Ertekin Ö; Kalron A; Feys P
    Phys Ther; 2022 Jul; 102(7):. PubMed ID: 35358308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using machine learning algorithms to detect fear of falling in people with multiple sclerosis in standardized gait analysis.
    Schumann P; Trentzsch K; Stölzer-Hutsch H; Jochim T; Scholz M; Malberg H; Ziemssen T
    Mult Scler Relat Disord; 2024 Aug; 88():105721. PubMed ID: 38885599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gait pattern changes after six-minute walk test in persons with multiple sclerosis.
    Escudero-Uribe S; Hochsprung A; Izquierdo-Ayuso G
    Physiother Res Int; 2019 Jan; 24(1):e1741. PubMed ID: 30192036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical assessment, management, and rehabilitation of walking impairment in MS: an expert review.
    Soler B; Ramari C; Valet M; Dalgas U; Feys P
    Expert Rev Neurother; 2020 Aug; 20(8):875-886. PubMed ID: 32729742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of wearing a dorsiflexion assist orthosis on mobility, perceived fatigue and exertion during the six-minute walk test in people with multiple sclerosis: a randomised cross-over protocol.
    McLoughlin J; Barr C; Sturnieks D; Lord S; Crotty M
    BMC Neurol; 2012 May; 12():27. PubMed ID: 22625433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of functional outcome measures after fampridine treatment in patients with multiple sclerosis - An interventional follow-up study.
    Skov CD; Sørensen CB; Thorning M; Lambertsen KL; Frich LH; Jensen HB; Holsgaard-Larsen A; Nielsen HH
    Mult Scler Relat Disord; 2022 Oct; 66():104034. PubMed ID: 35843140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deterioration of specific aspects of gait during the instrumented 6-min walk test among people with multiple sclerosis.
    Shema-Shiratzky S; Gazit E; Sun R; Regev K; Karni A; Sosnoff JJ; Herman T; Mirelman A; Hausdorff JM
    J Neurol; 2019 Dec; 266(12):3022-3030. PubMed ID: 31493037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Multifactorial Model of Multiple Sclerosis Gait and Its Changes Across Different Disability Levels.
    Angelini L; Buckley E; Bonci T; Radford A; Sharrack B; Paling D; Nair KPS; Mazza C
    IEEE Trans Biomed Eng; 2021 Nov; 68(11):3196-3204. PubMed ID: 33625975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fampridine-induced changes in walking kinetics are associated with clinical improvements in patients with multiple sclerosis.
    Weller D; Lörincz L; Sutter T; Reuter K; Linnebank M; Weller M; Zörner B; Filli L
    J Neurol Sci; 2020 Sep; 416():116978. PubMed ID: 32559515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and patterns of subclinical motor and cognitive impairments in non-disabled individuals with early multiple sclerosis: A multicenter cross-sectional study.
    Cattaneo D; Gervasoni E; Anastasi D; Di Giovanni R; Brichetto G; Carpinella I; Cavalla P; Confalonieri P; Groppo E; Prosperini L; Tacchino A; Rovaris M; Solaro C
    Ann Phys Rehabil Med; 2022 Jan; 65(1):101491. PubMed ID: 33454397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profiling walking dysfunction in multiple sclerosis: characterisation, classification and progression over time.
    Filli L; Sutter T; Easthope CS; Killeen T; Meyer C; Reuter K; Lörincz L; Bolliger M; Weller M; Curt A; Straumann D; Linnebank M; Zörner B
    Sci Rep; 2018 Mar; 8(1):4984. PubMed ID: 29563533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inter-joint coordination during gait in people with multiple sclerosis: A focus on the effect of disability.
    Pau M; Leban B; Massa D; Porta M; Frau J; Coghe G; Cocco E
    Mult Scler Relat Disord; 2022 Apr; 60():103741. PubMed ID: 35305428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Objective sensor-based gait measures reflect motor impairment in multiple sclerosis patients: Reliability and clinical validation of a wearable sensor device.
    Flachenecker F; Gaßner H; Hannik J; Lee DH; Flachenecker P; Winkler J; Eskofier B; Linker RA; Klucken J
    Mult Scler Relat Disord; 2020 Apr; 39():101903. PubMed ID: 31927199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The rate of force relaxation scaling factor is highly sensitive to detect upper and lower extremity motor deficiencies in mildly affected people with multiple sclerosis.
    Uygur M; Barone DA
    Mult Scler Relat Disord; 2023 Sep; 77():104897. PubMed ID: 37481819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the impact of fatigue related to walking capacity and perceived ability in persons with multiple sclerosis? A multicenter study.
    Dalgas U; Langeskov-Christensen M; Skjerbæk A; Jensen E; Baert I; Romberg A; Santoyo Medina C; Gebara B; Maertens de Noordhout B; Knuts K; Béthoux F; Rasova K; Severijns D; Bibby BM; Kalron A; Norman B; Van Geel F; Wens I; Feys P
    J Neurol Sci; 2018 Apr; 387():179-186. PubMed ID: 29571860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smartwatch-derived sleep and heart rate measures complement step counts in explaining established metrics of MS severity.
    Woelfle T; Pless S; Reyes Ó; Wiencierz A; Kappos L; Granziera C; Lorscheider J
    Mult Scler Relat Disord; 2023 Dec; 80():105104. PubMed ID: 37913676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of laboratory gait analysis for understanding gait deterioration in people with multiple sclerosis.
    Cofré Lizama LE; Khan F; Lee PV; Galea MP
    Mult Scler; 2016 Dec; 22(14):1768-1776. PubMed ID: 27364324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combining a supervised and home-based task-oriented circuit training improves walking endurance in patients with multiple sclerosis. The MS_TOCT randomized-controlled trial.
    Straudi S; De Marco G; Martinuzzi C; Baroni A; Lamberti N; Brondi L; Da Roit M; Pizzongolo LDM; Basaglia N; Manfredini F
    Mult Scler Relat Disord; 2022 Apr; 60():103721. PubMed ID: 35276451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise-induced changes in gait kinematics in multiple sclerosis with minimal neurological disability.
    Andreopoulou G; Mercer TH; Enriquez JG; Justin M; MacLeod N; Harrison E; Mahad DJ; van der Linden ML
    Mult Scler Relat Disord; 2021 Jan; 47():102630. PubMed ID: 33232909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of Walking-Related Motor Fatigue in Persons With Multiple Sclerosis: Decline in Walking Distance Induced by the 6-Minute Walk Test.
    Leone C; Severijns D; Doležalová V; Baert I; Dalgas U; Romberg A; Bethoux F; Gebara B; Santoyo Medina C; Maamâgi H; Rasova K; Maertens de Noordhout B; Knuts K; Skjerbaek A; Jensen E; Wagner JM; Feys P
    Neurorehabil Neural Repair; 2016 May; 30(4):373-83. PubMed ID: 26216790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.